Actos Bladder Cancer Lawsuit Consultations Available

Share Article

Resource4thePeople Attorneys Continue to Offer Free Consultations for Actos Bladder Cancer Lawsuits

The national network of defective drug lawyers at Resource4thePeople is announcing that they are continuing to accept clients who are seeking to file Actos bladder cancer lawsuits.

The announcement comes as hundreds of Actos lawsuits are being consolidated before a federal judge in Illinois on behalf of victims who have suffered Actos side effects that have severely damaged their health.

Resource4thePeople attorneys have been concerned that there may be some confusion about whether new Actos victims are eligible to come forth and seek compensation for the devastating medical costs, loss of wages, pain and suffering and other expenses they have incurred because they have been diagnosed with bladder cancer.

The fact is that even though there may be time limits involved in some cases most Actos victims likely remain eligible to file such lawsuits. Free consultations are being offered by our lawyers to victims who are seeking experienced, aggressive legal representation.

The consultations are structured to offer Actos victims a comprehensive review of the legal options that may be available to them.

The lawyers at Resource4thePeople note that there have been increasing numbers of Actos victims seeking legal assistance as more medical research and findings by consumer organizations increase questions about whether Actos (pioglitazone) is a safe medication for the treatment of diabetes and whether it was properly tested and adequately scrutinized before this link to bladder cancer was revealed.

They note that this is particularly relevant during November, which is American Diabetes Month as our attorneys express their awareness and concern for the estimated 25 million American diabetics.

Actos has been one of the top-selling medications in the country since it was introduced into the marketplace by Asian drug giant Takeda Pharmaceuticals 12 years ago as the newest and best medication to treat type-2 diabetes.

As with any drug, there were warnings of generic side effects but the question of the safety of Actos began being seriously questioned after medical researchers discovered links to bladder cancer and Actos victims began coming forth with Actos bladder cancer lawsuits.

As increasing numbers of Actos bladder cancer victims surfaced France and Germany pulled Actos from pharmacy shelves in those countries and the U.S. Food and Drug Administration issued health warnings about the increased risk of suffering bladder cancer among Actos patients.

The federal agency also warned health care professionals about the dangers of long-term use of Actos. Our Actos attorneys also have noticed that the non-profit consumer group Public Citizen has classified Actos as a “Do Not Use” medication because of this dangerous side effect.
Here’s what the consumer group had to say about Actos (pioglitazone):

“If you are taking pioglitazone or a pioglitazone-containing product, you should consult your physician about switching to equally effective and safer drugs for type-2 diabetes. Exercise and diet can also be instrumental in controlling blood sugar levels.”

Resource4thePeople attorneys also point out that Actos is still generating huge profits for Takeda even though the FDA has issued health warnings about the bladder cancer dangers and recommended against long-term use of the drug because of the bladder cancer link.

The company in 2010 reported that more than 11 million prescriptions were dispensed and sales exceeded $2.5 billion.

Resource4thePeople attorneys are among those who are investigating claims on behalf of Actos bladder cancer victims and encourage any victims of this side effect to contact us as soon as possible for experienced, aggressive representation.

http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html

Share article on social media or email:

View article via:

Pdf Print

Contact Author

W.J. Callahan
Resource4thePeople
800 580-8490
Email >
Visit website